Equipped with customized search, customers can explore on-demand seminars and technical literature

Thermo Scientific RadEye PRD4/PRD-ER4 provides early warning detection alerts enabling accelerated decision-making regarding on-site radiation levels

Brings unmatched scalability, flexibility and expertise to enable customers to navigate through the pandemic.

New platform provides faster identification of defects that impact device performance

Thermo Scientific Gemini Analyzer with LowDoseID for narcotics analysis eliminates concentration limitations from testing process

Collaboration will include development of Thermo Fisher products and strategic manufacturing support

Company extends program benefits to oncology laboratories and fast-tracks access to comprehensive molecular profiling on the Genexus System

Thermo Fisher Scientific's ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites

Thermo Scientific Sentinel 1000 Selectscan Metal Detector is designed to quickly and safely detect objects 25% smaller in volume than legacy systems

Leading pharma services network brings unmatched scalability, flexibility and expertise to support the global response

Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan

Next-Generation Sequencing solutions of Thermo Fisher Scientific help identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients

Agreement centers on identifying HER2 gene mutations using Oncomine Dx Target Test

Reliable, easy-to-use cryo-EM workflow solution quadruples throughput for pharma labs

Designation follows recent announcement on development of first companion diagnostic using the Oncomine Precision Assay on the new Ion Torrent Genexus System

Agreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution

Expansions enable customers to bring transformative medicines to market faster

New software can be used by pharma, biotech labs to comply with Title 21 CFR Part 11 data integrity regulations

Digital programs will enable scientists to broaden mass spectrometry-based research, from proteomics and biotherapeutics to clinical applications